Although this study confirms the beneficial effects of ISO on neuroinflammation and its modulation of the MAPK/NF-κB pathway, it should be noted that, given the multifactorial nature of AD pathology, our investigation represents only an initial step. This evidence concerns the gene NFKB1 and Alzheimer disease.